Guardtech Cleanrooms has recently delivered several repurposing jobs for clients including Contamac, Brunel University and B&S Group.
Contamac needed an ISO7 optical cleanroom to be designed and constructed in an existing building that required a significant repurposing. This included the design of all mechanical and electrical services for the building as well as the related process equipment.
Brunel University charged Guardtech with the relocation of an ISO6 cleanroom for its work in organic electronics, while B&S Group required a relocation for its 300 sqm Grade D cleanroom.
Inca needed its HVAC system to be relocated in its ISO8 cleanroom for digital printing, while Unipart drafted in Guardtech to provide an extension to its automotive ISO8 cleanroom.
SPTS, a business that provides advanced wafer-processing technologies and solutions for the semiconductor and microelectronics industries, required its ISO4 cleanroom to be repurposed over the Christmas period. The existing ceiling and HEPA filters had to be replaced, a ceiling that was almost entirely made up of filters, with teardrop lighting underneath.
Just as they did for Ultra Vision, world-class specialists in developing leading-edge technology for contact lenses.
Guardtech converted Ultra Vision’s CNC laboratory into an ISO7 cleanroom, ensuring its cast-moulded and lathe-cutting systems could continue to produce the contact lens solutions.
The company also completed a project to build a non-classified QC laboratory, Grade D packaging facility and Grade D manufacturing area for generics firm Noumed Life Sciences, producing a site that was described as by an inspector to the client as “as good a facility as he has been in”.
Guardtech’s Commercial Director Mark Wheeler said: “We’ve been involved in so many repurposing jobs now,” he said, “and seeing the positive impact that our influence has on the success of these businesses is heart-warming. Whether it’s an upscale, upgrade or relocation project, we put the same amount of care, hard work and forward-thinking into every job we undertake.”
Many pharmaceutical firms are switching from traditional therapies to cell and gene-therapy. Mr Wheeler added that Guardtech are working around the clock to upscale and repurpose plants to meet this demand, using rapid design techniques and quick-build processes.
